WorthamJMHaddadMBStewartRJ, et al. Second nationwide tuberculosis outbreak caused by bone allografts containing live cells—United States, 2023. MMWR Morb Mortal Wkly Rep. 2024;72(5253):1385-1389.
2.
SchwartzNGHernandez-RomieuACAnnambhotlaP, et al. Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report. Lancet Infect Dis. 2022;22(11):1617-1625.
3.
LiRDeutsch-FeldmanMAdamsT, et al. Transmission of mycobacterium tuberculosis to healthcare personnel resulting from contaminated bone graft material, United States, June 2021-August 2022. Clin Infect Dis. 2023;76(10):1847-1849.
4.
HillCPurtillD.Learning from the bone allograft tuberculosis outbreak in the USA. Lancet Infect Dis. 2022;22(11):1522-1523.
5.
McVeighLGZaazoueMALaneBCVoorhiesJMBradburyJ.Management and outcomes of surgical site tuberculosis infection due to infected bone graft in spine surgery: a single-institution experience and 1-year postoperative follow-up. J Neurosurg Spine. 2023;38(2):281-292.
6.
RuanTNaveedMVienH.Case report: tuberculosis recall on bone graft patient. N Am Spine Soc J. 2023;15:100241.
7.
HofmannNLafargeXAnticaM, et al. Expert consideration on regulatory aspects for perinatal derivatives in clinical settings. Stem Cells Transl Med. 2023;12(5):258-265.
8.
De KorteDDelabieWFeysHB, et al. Towards standardized human platelet lysate production in Europe: an initiative of the European Blood Alliance. Vox Sang. 2024;119(1):79-87.
9.
Schuantes-PaimSMWachholzLFKnihsNDSDe OliveiraPCRozaBASchirmerJ.Adverse events reporting systems in cells, organs, and tissues donation and transplantation: scoping review. Transplant Proc. 2023;55(6):1352-1358.
